Literature DB >> 26341250

Plasma levels of oxidative stress in children with steroid-sensitive nephrotic syndrome and their predictive value for relapse frequency.

Aiwen Fan1, Xiaoyun Jiang2, Ying Mo3, Huizhen Tan1, Mengjie Jiang3, Jinhua Li4.   

Abstract

BACKGROUND: Oxidative stress has been reported to play an important role in children with primary nephrotic syndrome (PNS). However, the results of previous studies are controversial.
METHODS: Forty children with steroid-sensitive nephrotic syndrome (SSNS) and 20 age- and sex-matched healthy controls were enrolled. Patients were followed-up for 12-18 months and divided into three subgroups: frequent relapse (n = 10), non-frequent relapse (n = 12), and non-relapse (n = 18). The plasma levels of advanced oxidation protein products (AOPP), malondialdehyde (MDA), and superoxide dismutase (SOD) were tested in controls and patient group at first presentation and after 4 weeks of steroid treatment.
RESULTS: Patients had higher AOPP and MDA levels but lower SOD compared with controls. AOPP levels were significantly higher in the frequent relapse subgroup compared with the non-frequent relapse and non-relapse subgroups, respectively. No significant differences were found in the plasma levels of MDA and SOD among the three subgroups. AOPP >87.55 μmol/l before steroid treatment and AOPP >78.5 μmol/l after 4-week steroid treatment were positively correlated with the relapse frequency in patients with SSNS.
CONCLUSIONS: Children with SSNS have oxidative stress. The plasma levels of AOPP before and after 4-week steroid treatment may predict whether patients with SSNS will relapse frequently.

Entities:  

Keywords:  Children; Oxidative stress; Relapse; Steroid-sensitive nephrotic syndrome

Mesh:

Substances:

Year:  2015        PMID: 26341250     DOI: 10.1007/s00467-015-3195-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  [Evidence-based guidelines on diagnosis and treatment of childhood common renal diseases. (I) Evidence-based guideline on diagnosis and treatment of steroid-sensitive, relapsing/steroid-dependent nephrotic syndrome (for trial implementation)].

Authors: 
Journal:  Zhonghua Er Ke Za Zhi       Date:  2009-03

2.  Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome.

Authors:  Aydin Ece; Yildiz Atamer; Fuat Gürkan; Meki Bilici; Yüksel Koçyiğit
Journal:  Nephrology (Carlton)       Date:  2004-12       Impact factor: 2.506

3.  Risk factors for steroid dependency in children with idiopathic nephrotic syndrome.

Authors:  H K Yap; E J Han; C K Heng; W K Gong
Journal:  Pediatr Nephrol       Date:  2001-12       Impact factor: 3.714

4.  CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life.

Authors:  Sailaja Elchuri; Terry D Oberley; Wenbo Qi; Richard S Eisenstein; L Jackson Roberts; Holly Van Remmen; Charles J Epstein; Ting-Ting Huang
Journal:  Oncogene       Date:  2005-01-13       Impact factor: 9.867

5.  Oxidative stress is increased in critically ill patients with acute renal failure.

Authors:  Jonathan Himmelfarb; Ellen McMonagle; Stephanie Freedman; Jennifer Klenzak; Elizabeth McMenamin; Phuong Le; Lara B Pupim; T Alp Ikizler
Journal:  J Am Soc Nephrol       Date:  2004-09       Impact factor: 10.121

Review 6.  Nephrotic syndrome in childhood.

Authors:  Allison A Eddy; Jordan M Symons
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

7.  Oxidative stress in pediatric nephrotic syndrome.

Authors:  Rajani Kamireddy; Suchitra Kavuri; Sri Devi; Harathi Vemula; Devi Chandana; Salini Harinarayanan; Reena James; Anjali Rao
Journal:  Clin Chim Acta       Date:  2002-11       Impact factor: 3.786

Review 8.  Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors.

Authors:  A Negre-Salvayre; C Coatrieux; C Ingueneau; R Salvayre
Journal:  Br J Pharmacol       Date:  2007-07-23       Impact factor: 8.739

Review 9.  Immune dysregulation in minimal change nephropathy.

Authors:  Peter W Mathieson
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

10.  Advanced oxidation protein products as a novel marker of oxidative stress in uremia.

Authors:  V Witko-Sarsat; M Friedlander; C Capeillère-Blandin; T Nguyen-Khoa; A T Nguyen; J Zingraff; P Jungers; B Descamps-Latscha
Journal:  Kidney Int       Date:  1996-05       Impact factor: 10.612

View more
  4 in total

1.  NOX-mediated impairment of PDGF-induced DNA synthesis in peripheral blood lymphocytes of children with idiopathic nephrotic syndrome.

Authors:  Amal Al-Eisa; Gursev S Dhaunsi
Journal:  Pediatr Res       Date:  2017-06-14       Impact factor: 3.756

2.  Increased ischemia-modified albumin levels in children with steroid-sensitive nephrotic syndrome.

Authors:  Gokhan Cakirca; Ahmet Guzelcicek; Kenan Yilmaz; Cemal Nas
Journal:  Pak J Med Sci       Date:  2020 Nov-Dec       Impact factor: 1.088

Review 3.  Klotho: A Possible Role in the Pathophysiology of Nephrotic Syndrome.

Authors:  Sojit Tomo; Amandeep Birdi; Dharmveer Yadav; Manish Chaturvedi; Praveen Sharma
Journal:  EJIFCC       Date:  2022-04-11

4.  Predictors of frequent relapsing and steroid-dependent nephrotic syndrome in children.

Authors:  B Dakshayani; Manjula Lakshmanna; R Premalatha
Journal:  Turk Pediatri Ars       Date:  2018-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.